Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > WHAT the F ???

<< Previous

Bullboard Posts

Next >>

Comment by The300on Jun 02, 2011 5:07pm

297 Views

Post# 18664350

RE: WHAT the F ???

I am just dumbfounded

It's not even a good news release. Why re-release it?????

Is there anyone overlooking this company???? Management has very little skin in the game (their own cash on the line - not including warrants or options - as per SEDI) As such I'm guessing their focus must be elsewhere as its not on Halo and definitely not on its shareholders.

It might be time for Pinetree to consider running a slate at the next AGM and appointing a new executive team. They've got my 200,000 shares.

Confused and dissappointed once more

The 300

<< Previous

Bullboard Posts

Next >>

Level up your trading with BMO InvestorLine’s enhanced features